Immunoprofiling for advanced biomarker discovery
Sengenics at a glance
Sengenics is a proteomics company with a unique technology used to produce full-length, correctly folded, and functional proteins. The technology is leveraged to support pharma and academic research to advance precision medicine through an increased understanding of the autoimmune response in humans. Sengenics is currently focused on measurement of autoantibodies for applications in autoimmune diseases, oncology, neurological conditions, and infectious disease.
Year acquired
Sector
Employees
Website
Investment themes
The challenges we face
We currently suffer from ineffective medication due to limited understanding of the biology of diseases. The shift from the "one size fits all" approach to precision medicine is a colossal challenge for science. Development of autoantibody biomarker signatures enable improved understanding of human biology and can optimize the development of safer and higher efficacy drugs, hence enabling healthcare to become more personalized and for the right treatment to be delivered to the right patient at the appropriate time.
of patients receive no benefit from treatment with the top 10 best-selling drugs in the world.
of OECD GDP is spent on healthcare.
How does Sengencis help?
Reality today
We do not understand the biology of many leading diseases and lack appropriate biomarkers, preventing us from developing effective medication and delivering precision treatment.
Sengencis approach
Sengenics proteomics technology enables biological response research at unrivalled sensitivity and specificity, helping develop more targeted, effective, and efficient diagnostics and therapies.
Aspirational future
Deeper understanding of human biology and disease allows us to develop and deliver the most effective diagnostics and treatments for patients.
Who is impacted?
Researchers are impacted directly through more effective tools to understand human biology. Patients are impacted indirectly through breakthroughs in treatments.
What are the impact considerations?
Additionality
Sengenics unique technology and collaborative partnerships with top biopharma companies is driving forward precise, cost-effective research that would not otherwise be possible.
Risks
Sengenics impact depends in part on how its customers in biopharma choose to use its tools. Product quality is also fundamentally important, enabling reproducibility in research and precise, safe innovation in therapies.
SDG alignments
